U10-CA-69651/CA/NCI NIH HHS/United States[Grant Number] - Search Results

Year	Number of Results
1998	1
1999	2
2001	7
2002	4
2003	3
2004	8
2005	3
2006	5
2007	5
2008	3
2009	10
2010	13
2011	7
2012	8
2013	11
2014	3
2015	9
2022	0

1

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Romond EH, Perez EA, Bryant J, Suman VJ, Geyer CE Jr, Davidson NE, Tan-Chiu E, Martino S, Paik S, Kaufman PA, Swain SM, Pisansky TM, Fehrenbacher L, Kutteh LA, Vogel VG, Visscher DW, Yothers G, Jenkins RB, Brown AM, Dakhil SR, Mamounas EP, Lingle WL, Klein PM, Ingle JN, Wolmark N. Romond EH, et al. N Engl J Med. 2005 Oct 20;353(16):1673-84. doi: 10.1056/NEJMoa052122. N Engl J Med. 2005. PMID: 16236738 Free article. Clinical Trial.

2

Gene expression and benefit of chemotherapy in women with node-negative, estrogen receptor-positive breast cancer.

Paik S, Tang G, Shak S, Kim C, Baker J, Kim W, Cronin M, Baehner FL, Watson D, Bryant J, Costantino JP, Geyer CE Jr, Wickerham DL, Wolmark N. Paik S, et al. J Clin Oncol. 2006 Aug 10;24(23):3726-34. doi: 10.1200/JCO.2005.04.7985. Epub 2006 May 23. J Clin Oncol. 2006. PMID: 16720680

3

Long-term outcomes of invasive ipsilateral breast tumor recurrences after lumpectomy in NSABP B-17 and B-24 randomized clinical trials for DCIS.

Wapnir IL, Dignam JJ, Fisher B, Mamounas EP, Anderson SJ, Julian TB, Land SR, Margolese RG, Swain SM, Costantino JP, Wolmark N. Wapnir IL, et al. J Natl Cancer Inst. 2011 Mar 16;103(6):478-88. doi: 10.1093/jnci/djr027. Epub 2011 Mar 11. J Natl Cancer Inst. 2011. PMID: 21398619 Free PMC article. Clinical Trial.

4

Twenty-five-year follow-up of a randomized trial comparing radical mastectomy, total mastectomy, and total mastectomy followed by irradiation.

Fisher B, Jeong JH, Anderson S, Bryant J, Fisher ER, Wolmark N. Fisher B, et al. N Engl J Med. 2002 Aug 22;347(8):567-75. doi: 10.1056/NEJMoa020128. N Engl J Med. 2002. PMID: 12192016 Free article. Clinical Trial.

5

Twenty-year follow-up of a randomized trial comparing total mastectomy, lumpectomy, and lumpectomy plus irradiation for the treatment of invasive breast cancer.

Fisher B, Anderson S, Bryant J, Margolese RG, Deutsch M, Fisher ER, Jeong JH, Wolmark N. Fisher B, et al. N Engl J Med. 2002 Oct 17;347(16):1233-41. doi: 10.1056/NEJMoa022152. N Engl J Med. 2002. PMID: 12393820 Free article.

6

Oxaliplatin as adjuvant therapy for colon cancer: updated results of NSABP C-07 trial, including survival and subset analyses.

Yothers G, O'Connell MJ, Allegra CJ, Kuebler JP, Colangelo LH, Petrelli NJ, Wolmark N. Yothers G, et al. J Clin Oncol. 2011 Oct 1;29(28):3768-74. doi: 10.1200/JCO.2011.36.4539. Epub 2011 Aug 22. J Clin Oncol. 2011. PMID: 21859995 Free PMC article. Clinical Trial.

7

Ductal carcinoma in situ: an overview.

Duggal S, Robin J, Julian TB. Duggal S, et al. Expert Rev Anticancer Ther. 2013 Aug;13(8):955-62. doi: 10.1586/14737140.2013.820557. Expert Rev Anticancer Ther. 2013. PMID: 23984897 Review.

8

Ductal carcinoma in situ: a rose by any other name.

Wickerham DL, Julian TB. Wickerham DL, et al. J Natl Cancer Inst. 2013 Oct 16;105(20):1521-2. doi: 10.1093/jnci/djt268. Epub 2013 Sep 25. J Natl Cancer Inst. 2013. PMID: 24068770 Free PMC article. No abstract available.

9

The impact of systemic therapy following ductal carcinoma in situ.

Eng-Wong J, Costantino JP, Swain SM. Eng-Wong J, et al. J Natl Cancer Inst Monogr. 2010;2010(41):200-3. doi: 10.1093/jncimonographs/lgq021. J Natl Cancer Inst Monogr. 2010. PMID: 20956830 Free PMC article. Review.

10

The need for axillary dissection in patients with positive axillary sentinel lymph nodes.

Croshaw RL, Erb KM, Shapiro-Wright HM, Julian TB. Croshaw RL, et al. Curr Oncol Rep. 2011 Feb;13(1):5-10. doi: 10.1007/s11912-010-0133-0. Curr Oncol Rep. 2011. PMID: 20957459 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results